Login to Your Account

Ampio seeks $59.5M to move pain candidate Ampion to goal line

By Marie Powers
Staff Writer

Friday, February 28, 2014
Ampio Pharmaceuticals Inc. priced an underwritten public offering of 8.5 million shares of common stock at $7 apiece, seeking to raise $59.5 million. The offering price represented a discount of 11.8 percent to Ampio’s (NYSE MKT:AMPE) closing price of $7.94 on Thursday, but the offering was upsized from the 8 million shares cited in the company’s preliminary prospectus supplement, dated Feb. 24.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription